Related Experiment Video
Updated: Jun 9, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
[cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells]
B Hirsch1, F K Braun, N Al-Yacoub
1Institut für Pathologie, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin. burkhard.hirsch@charite.de
Abstract:
Stimulation of the TNF receptors CD30 and CD95 exerts opposite effects. Crosstalk of both receptors is unknown. We aimed to reveal regulatory mechanisms of CD30-induced effects on CD95 signaling of cALCL cell lines. "CD30/CD95 crosstalk analysis" was performed in cALCL cell lines by comparison of CD30 or CD95 stimulation and CD30/CD95 costimulation. Receptor expression and induction of apoptosis was investigated by flow cytometry. mRNA expression of CD30-inducible genes (cFLIP, TRAF1, cIAP2, and A20) was compared by semiquantitative reverse transcription (RT-RQ-) PCR in stimulated and unstimulated cells. Protein expression of IκBα, p100/p52, caspase-8, caspase-3, and cFLIP was analyzed by immunoblotting. A lentiviral-based shRNA-mediated approach was used to inhibit cFLIP expression. CD30/CD95 crosstalk experiments revealed that CD30 ligation leads to NFκB-mediated cFLIP upregulation in cALCL cells, which in turn enhanced resistance to CD95-mediated apoptosis. This effect is based on the CD30-induced upregulation of cFLIP. Knockdown of cFLIP restores sensitivity to CD95-mediated apoptosis. We conclude that the anti-apoptotic function of CD30 antibodies should be kept in mind if CD30 antibody-based therapeutic concepts for ALCL lymphoma are considered.
Insights
CD30 receptor stimulation upregulates cFLIP, enhancing resistance to CD95-mediated apoptosis in cALCL cells. Inhibiting cFLIP restores apoptosis sensitivity, suggesting caution with CD30 antibody therapies for ALCL.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Tumor necrosis factor (TNF) receptors CD30 and CD95 have opposing effects.
- The crosstalk between CD30 and CD95 signaling is not well understood.
- Understanding this interaction is crucial for ALCL (anaplastic large cell lymphoma) pathogenesis and therapy.
Purpose of the Study:
- To investigate the regulatory mechanisms of CD30-induced effects on CD95 signaling in cALCL cell lines.
- To elucidate the crosstalk between CD30 and CD95 signaling pathways.
- To determine the role of cFLIP in CD30/CD95 crosstalk and apoptosis resistance.
Main Methods:
- Flow cytometry was used to assess receptor expression and apoptosis induction.
- RT-RQ-PCR and immunoblotting analyzed mRNA and protein expression of key signaling molecules (cFLIP, TRAF1, IκBα, caspases).
- Lentiviral shRNA mediated knockdown of cFLIP to assess its functional role.
Main Results:
- CD30 ligation induced NFκB-mediated upregulation of cFLIP in cALCL cells.
- Upregulated cFLIP conferred resistance to CD95-mediated apoptosis.
- Knockdown of cFLIP restored sensitivity to CD95-induced apoptosis, confirming cFLIP's critical role.
Conclusions:
- CD30 signaling promotes apoptosis resistance in cALCL cells via cFLIP upregulation.
- The anti-apoptotic function of CD30 antibodies warrants consideration in therapeutic strategies for ALCL.
- Targeting cFLIP may represent a therapeutic avenue for overcoming resistance in ALCL.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
